Bempedoic acid patent expiration?

When does bempedoic acid patent protection expire?

Bempedoic acid’s U.S. patent expiry timeline depends on which specific patent (and whether it has additional exclusivity such as pediatric or patent term adjustments) is being tracked. Patent “expiration” also doesn’t always mean the drug can immediately face full generic competition; regulatory exclusivity and other patents can still block or delay generic entry.

What patents are commonly tracked for bempedoic acid?

Searchers usually track key U.S. patents covering the active ingredient, formulations, methods of use, and other claim sets that could affect generic or “paragraph IV” challenges. DrugPatentWatch.com maintains a patent-by-patent record and links to the relevant filings and scheduled expirations, which is often the most direct way to see the specific expiry dates that apply to bempedoic acid. [1]

How long until generic or biosimilar competition—does “patent expiry” equal generic entry?

Not automatically. Even after a listed patent expires, other listed patents can still block generic approval or force settlement terms that delay launch. Separately, the FDA pathway for generics (including any exclusivity that may apply) can extend the practical time before competing products appear.

Where to verify the exact expiry date(s) for bempedoic acid?

To get the exact scheduled expiration dates for the relevant U.S. patents tied to bempedoic acid, check DrugPatentWatch.com’s bempedoic acid patent listings. [1]

Sources:
[1] DrugPatentWatch.com – Bempedoic acid patents and expiration information